No abstract available.
Behavior Therapy* ; Self-Injurious Behavior*

OBJECTIVE: This study aimed to determine the methods of self-injurious behavior and related psychiatric disorder among patients seen at Baguio General Hospital and Medical Center. METHODS: This was a cross-sectional study which used convenience sampling. It involved 53 patients with self-injurious behavior brought to Baguio General Hospital and Medical Center and assessed by the Department of Psychiatry. Data was gathered through a Psychiatric interview done by a co-investigator to eliminate interviewer’s bias. Statistical analyses used were both descriptive (percentages, mean, and frequency) and inferential in the form of chisquare test. RESULTS: Socio-demographic profile of patients showed that the mean age of patients with self-injurious behavior was 26-27 (26.8), predominantly female, single and high school graduate. For the factors leading to self-injury, it showed that self-injurious patients had a family history of psychiatric disorder and a previous history of self-injury. The predominant method used by the patients in the study was ingestion. The major psychiatric disorder found among patients was Depressive Disorder. There was no association noted between the method of self-injurious behavior employed and the specific psychiatric disorder. CONCLUSION Patients brought to the hospital due to self-injury commonly had an ongoing psychiatric pathology, majority of whom had a Depressive Disorder. Since the method used for self-injury was not found to be associated with the type of psychiatric disorder, it would be too risky to conclude that patients with minor methods of self-injury ( e.g. scratching) would only have a minor psychiatric disturbance. It is, therefore, recommended that a comprehensive psychiatric assessment should be conducted for all patients with self-injurious behavior irrespective of the level of lethality of their method self-injury.
Self-Injurious Behavior ; Mental Disorders

No abstract available.
Adolescent* ; Humans ; Naloxone* ; Self-Injurious Behavior*

No abstract available.
Adolescent* ; Humans ; Pain Threshold* ; Self-Injurious Behavior*

No abstract available.
Adolescent* ; Humans ; Pain Threshold* ; Self-Injurious Behavior*

No abstract available.
Multiple Sclerosis, Chronic Progressive* ; Self-Injurious Behavior*

The relationship between suicidality and the loudness dependence of auditory-evoked potentials (LDAEP) remains controversial. This article reviews the literature related to the LDAEP and suicide in patients with major depressive disorder, and suggests future research directions. Serotonergic dysfunction in suicidality seems to be more complicated than was originally thought. Studies of suicide based on the LDAEP have produced controversial results, but it is possible that these are due to differences in study designs and the smallness of samples. For example, some studies have evaluated suicide ideation and the LDAEP, while others have evaluated suicide attempts and the LDAEP. Furthermore, some of the latter studies enrolled acute suicide attempters, while others enrolled those with the history of previous suicide attempts, irrespective of whether these were acute or chronic. Thus, a more robust study design is needed in future studies, for example by evaluating the LDAEP immediately after a suicide attempt rather than in those with a history of suicide attempts and suicide ideation in order to reduce bias. Moreover, genuine suicide attempt, self-injurious behaviors, and faked suicide attempt need to be discriminated in the future.
Bias (Epidemiology) ; Depressive Disorder, Major* ; Humans ; Self-Injurious Behavior ; Suicide*

Clozapine remains the treatment of choice in refractory schizophrenia despite its various requirement to prescribe, such as mandatory blood monitoring program and various metabolic complication. Currently, clozapine is recommended only after two failed adequate antipsychotics trials. We report a case of a successful early clozapine trial in the treatment of first-episode schizophrenia patient, considering poor treatment response and repeated self-injurious behavior. This case highlights the efficacy of an early clozapine trial as a second-line treatment for first-episode schizophrenia in contrast to switching or combination treatment strategy.
Antipsychotic Agents ; Clozapine* ; Humans ; Schizophrenia* ; Self-Injurious Behavior

Adolescent ; Humans ; Risk Factors ; Self-Injurious Behavior ; Surveys and Questionnaires

Adolescent ; Humans ; Risk Factors ; Self-Injurious Behavior ; Surveys and Questionnaires